RecruitingNot ApplicableNCT06094608

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms


Sponsor

University of Michigan

Enrollment

68 participants

Start Date

Feb 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Biopsy-proven IBD
  • Active IBD symptoms
  • Impaired IBD quality of life
  • Age \>/=18 years old
  • Fluency in English
  • Physically able to travel for study visits

Exclusion Criteria11

  • Ileostomy, colostomy, ileoanal pouch, or ileorectal anastomoses, are planned for imminent surgery and/or have short bowel syndrome
  • Other significant chronic disease
  • Retinal pathology, history of eye surgery, taking photosensitizing medications
  • Recent history of light treatment
  • Lifetime psychotic or bipolar disorder
  • Acute suicidal ideation
  • Substance use disorder in the past 3 months, cannabis use \>1/week
  • High risk for or diagnosed with obstructive sleep apnea, and/or narcolepsy
  • Severe hearing problem, intellectual disability or serious cognitive impairment
  • Pregnant, trying to get pregnant, or breastfeeding
  • Night work or travel outside the eastern time zone in the past month

Interventions

DEVICEMorning light treatment

Light therapy via the Re-Timer. Participants will conduct light treatment in the mornings at home for one hour using Re-timer®.

BEHAVIORALTreatment-as-usual

Participants will not make modifications to their activities or sleep schedule.


Locations(1)

University of Michigan

Ann Arbor, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06094608


Related Trials